Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects
Pharmacological Reports · 14.11.2026
DOI: 10.1007/s43440-026-00924-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Reports, online erschienen am 14.11.2026. Verfasst von Aleksandra Mąsior und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Agency, Poland.
Abstract (Originalsprache)
Background
Tryptamide (TRP) is an experimental anti-inflammatory and analgesic drug with a favourable safety profile even at high doses. Since neuroinflammation is a significant contributor to the pathogenesis of various neurodegenerative diseases, in this study we screened for the potential direct neuroprotective effect of TRP in comparison to the classical anti-inflammatory compound, ibuprofen (Ibu), in cellular models of Parkinson’s disease.
Methods
We compared the effectiveness of TRP (1-300 µM) with Ibu (10–300 µM) against cell damage induced by oxidative stress inducers (H 2 O 2 and 6-hydroxydopamine, 6-OHDA), dopaminergic neurotoxin 1-methyl-4-phenylpyridinium ion (MPP(+)), and pro-apoptotic factors, staurosporine (St) and doxorubicin (Dox) in undifferentiated (UN-) and retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. The neuroprotective effects were evidenced by biochemical assays (MTT reduction and LDH release tests), morphology (microscopic evaluation), and caspase-3 activity, as well as validated in mouse primary mesencephalic neurons.
Results
We demonstrated that TRP and Ibu at concentrations up to 100 µM, when given for 24 and 48 h, did not evoke any detrimental effects in UN- and RA-SH-SY5Y cells, but induced some cytotoxicity at the highest concentration tested (300 µM) in UN-SH-SY5Y cells. TRP significantly attenuated the cytotoxic effect of MPP(+) in UN- and RA-SH-SY5Y cells and was protective against H 2 O 2 , St, and Dox only in differentiated cells, however, it did not attenuate the 6-OHDA-induced cell death in both cell phenotypes. Moreover, the protection of TRP against MPP(+) and St, but not against Dox, was associated with inhibition of caspase-3 activity. Ibu did not show any protection in either of the tested cell models or cell phenotypes, with the exception of minor protection (10 µM) against St in UN-SH-SY5Y cells. The effects of TRP were orthogonally confirmed by high-content imaging of Calcein AM/Hoechst 33,342-stained RA-SH-SY5Y cells exposed to MPP(+) and of tyrosine hydroxylase (TH)-immunostained mouse primary mesencephalic neurons exposed to MPP(+) or 6-OHDA.
Conclusions
Our results evidenced a neuroprotective potential of TRP against various cell-damaging factors, with its higher effectiveness in RA-SH-SY5Y cells in apoptotic, rather than oxidative stress-based neuronal cell damage models, which was also confirmed in primary mesencephalic neurons. TRP effects on RA-differentiated neurons were further validated by energy metabolism profile and high-content imaging in the MPP(+) model. Thus, TRP has neuroprotective potential, worth further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
- Neurodegeneration and Experimental Therapy Lab, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
- Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
- Department of Brain Biochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. danuta.jantas@if-pan.edu.pl.
ORCID-Profile: Danuta Jantas
Förderung
- Medical Research Agency, Poland
Zitieren
APA
Mąsior, A., Maziarz, K., Chmielarz, P., Kuter, K. Z., Maziak, A., Wilk, Z., Bugno, R., Bojarski, A. J., & Jantas, D. (2026). Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects. Pharmacological Reports. https://doi.org/10.1007/s43440-026-00924-9
Vancouver
Mąsior A, Maziarz K, Chmielarz P, Kuter KZ, Maziak A, Wilk Z, et al. Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects. Pharmacological Reports. 2026. doi:10.1007/s43440-026-00924-9
BibTeX
@article{Msior2026,
author = {Mąsior, Aleksandra and Maziarz, Katarzyna and Chmielarz, Piotr and Kuter, Katarzyna Z and Maziak, Agata and Wilk, Zuzanna and Bugno, Ryszard and Bojarski, Andrzej J and Jantas, Danuta},
title = {Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects},
journal = {Pharmacological Reports},
year = {2026},
doi = {10.1007/s43440-026-00924-9}
}
EUVIMED